Pain Medicine News

Pain Medicine News Pain Medicine News (PMN), is designed to meet the needs of the spectrum of physicians involved in managing pain, including pain specialists, primary care physicians, physiatrists, neurologists, orthopedic surgeons, rheumatologists, oncologists, etc.

Pain Medicine News (PMN), is designed to meet the needs of the spectrum of physicians involved in managing pain, including pain specialists, primary care physicians, physiatrists, neurologists, orthopedic surgeons, rheumatologists, oncologists, etc., and is mailed to 50,612 pain-treating physicians that are the highest-prescribers of pain medication in these specialties. This medical newspaper offers extensive coverage of pain related presentations at major clinical meetings and feature articles on topics relevant to practicing clinicians. PMN also presents in-depth clinical reviews written by thought leaders, cutting-edge practice management articles, medical education and CME activities.

Study Shows Intrathecal Bupivacaine Effective for Long-Term Cancer Pain Treatmenthttp://bit.ly/2W1B2SN“Treating cancer...
05/02/2019

Study Shows Intrathecal Bupivacaine Effective for Long-Term Cancer Pain Treatment

http://bit.ly/2W1B2SN

“Treating cancer pain with morphine is often effective, but it’s not without its problems,” said Anders Wincent, MD, a senior consultant at the Karolinska University Hospital in Stockholm. “Previously we found there was no analgesic benefit to adding morphine to intrathecal bupivacaine in severe cancer-related pain [Int J Clin Pharmacol Ther 2017;55(6):525-532]. So in this study we wanted to see if we could address this pain only with intrathecal bupivacaine.”

#PainMedicineNews #painmanagement #opioids #chronicpain #Neuropathy #NervePain #Painmedicine #jointpain #pain #medicine #painspecialists #persistentpain #pharma #pharmaceutical #DigitalHealth #HealthTalk #healthcare #healthinnovations #shingles #CDC #committee #FDA #intergrativemedicine #alternativemedicine #physicaltherapy #paintreatment #paintherapy

Oral Rinse Reduces Pain Caused by Cancer Treatmenthttp://bit.ly/2W1eBgn“Intractable pain from oral mucositis is a very...
05/01/2019
Oral Rinse Reduces Pain Caused by Cancer Treatment

Oral Rinse Reduces Pain Caused by Cancer Treatment

http://bit.ly/2W1eBgn

“Intractable pain from oral mucositis is a very common and debilitating disease process that occurs most often in patients undergoing head and neck radiation therapy, taking multiple types of chemotherapeutic agents, or undergoing hematopoietic stem cell transplant,” said Jaideep Mehta, MD, MBA, a pain medicine fellow at the University of Texas MD Anderson Cancer Center, in Houston.

“It can dramatically impair oral function, thereby impacting nutritional intake, quality of life and continuation of oral therapies among cancer patients,” he continued. “We also see a lot of therapeutic noncompliance as a result of this, and many times patients need to be rotated off their medications due to dose limitations.”

#PainMedicineNews #painmanagement #opioids #chronicpain #Neuropathy #NervePain #Painmedicine #jointpain #pain #medicine #painspecialists #persistentpain #pharma #pharmaceutical #DigitalHealth #HealthTalk #healthcare #healthinnovations #shingles #CDC #committee #FDA #intergrativemedicine #alternativemedicine #physicaltherapy #paintreatment #paintherapy

San Francisco—A Texas research team has found what seems to be a simple and cost-effective method for treating intractable oral pain associated with oral mucositis caused by cancer treatment: methylene blue oral rinse.

Pectoral Block Proven Effective As Motor Block, but Not Skin Sensory Blockhttp://bit.ly/2IQfXro“The PEC1 block was fir...
04/30/2019
Pectoral Block Proven Effective As Motor Block, but Not Skin Sensory Block

Pectoral Block Proven Effective As Motor Block, but Not Skin Sensory Block

http://bit.ly/2IQfXro

“The PEC1 block was first described by Blanco in 2011 [Anaesthesia 2011;66(9):847-848],” said Maxim Roy, MD, a resident at the University of Montreal. “The goal of the technique is to block the medial and lateral pectoral nerves by injecting anesthetic between the pectoralis major and pectoralis minor muscles. One year later, the same author proposed a modification of this technique, called the PEC2 block.

“Since the description of these blocks, the vast majority of literature has evaluated the PEC2 block,” he noted. “However, nobody has really proven that the PEC1 block actually blocks the lateral and medial pectoral nerves. What’s more, no standardized test exists for objectifying the presurgical success of the PEC1 block.”

#PainMedicineNews #painmanagement #opioids #chronicpain #Neuropathy #NervePain #Painmedicine #jointpain #pain #medicine #painspecialists #persistentpain #pharma #pharmaceutical #DigitalHealth #HealthTalk #healthcare #healthinnovations #shingles #CDC #committee #FDA #intergrativemedicine #alternativemedicine #physicaltherapy #paintreatment #paintherapy

Montreal—A team of Canadian researchers has confirmed that the PEC1 block is associated with significant motor block of the pectoral nerves, but without associated sensory block of the thoracic skin.

04/30/2019
FDA Speeds Up Approval for First Pediatric Lupus Treatment

FDA Speeds Up Approval for First Pediatric Lupus Treatment

http://bit.ly/2IQV67y

“The agency expedited the review and approval of this application because Benlysta IV fulfills an unmet need for therapies, specifically in pediatric patients with SLE,” said Janet Woodcock, MD, the director of the FDA’s Center for Drug Evaluation and Research. “While there is no cure for lupus, treatment can help our youngest patients control their disease with the hope of improving their quality of life and lowering their risk of long-term organ damage and disability.”

#PainMedicineNews #painmanagement #opioids #chronicpain #Neuropathy #NervePain #Painmedicine #jointpain #pain #medicine #painspecialists #persistentpain #pharma #pharmaceutical #DigitalHealth #HealthTalk #healthcare #healthinnovations #shingles #CDC #committee #FDA #intergrativemedicine #alternativemedicine #physicaltherapy #paintreatment #paintherapy

The FDA approved belimumab IV infusion for treatment of children with SLE, a serious chronic disease that causes inflammation and damage to various body tissues and organs.

Cardiac Surgery Patients With Persistent Opioid Use Incur More Complications, Longer Hospitalizationhttp://bit.ly/2W1qFy...
04/29/2019

Cardiac Surgery Patients With Persistent Opioid Use Incur More Complications, Longer Hospitalization

http://bit.ly/2W1qFyd

“OUD has been a growing problem across the country for several years now,” said principal investigator Edward Soltesz, MD, the surgical director of the Kaufman Center for Heart Failure Treatment and Recovery at the Cleveland Clinic, in Ohio. “Over the course of the 16-year study, we found the proportion of cardiac surgery patients with a history of OUD increased ninefold, from 0.06% of all cases in 1998 to 0.54% of all cases in 2013.”

#PainMedicineNews #painmanagement #opioids #chronicpain #Neuropathy #NervePain #Painmedicine #jointpain #pain #medicine #painspecialists #persistentpain #pharma #pharmaceutical #DigitalHealth #HealthTalk #healthcare #healthinnovations #shingles #CDC #committee #FDA #intergrativemedicine #alternativemedicine #physicaltherapy #paintreatment #paintherapy

04/27/2019
Keep Your Family Safe From Unused Opioid Pain Medicines (15 Secs)

Happy National Prescription Drug Take Back Day!

The FDA announced the launch of a new initiative to help decrease unnecessary exposure to opioids and prevent new addiction by focusing on the home.

The “Remove the Risk” campaign is targeting women aged 35 to 64 years, who are most likely to oversee household health care decisions and often serve as the gatekeepers to opioids and other prescription medications in the home.

“If every household removed prescription opioids once they’re no longer medically needed for their prescribed purpose it would have a major impact on the opioid crisis’ hold on American families and communities, ” said Amy Abernethy, MD, the principal deputy commissioner at the FDA.

Watch the PSA: https://youtu.be/9Qx1D5dW2LU

Read about it here: http://bit.ly/2DxPkDm

#PainMedicineNews #painmanagement #opioids #chronicpain #Neuropathy #NervePain #Painmedicine #jointpain #pain #medicine #painspecialists #persistentpain #pharma #pharmaceutical #DigitalHealth #HealthTalk #healthcare #healthinnovations #shingles #CDC #committee #FDA #intergrativemedicine #alternativemedicine #physicaltherapy #paintreatment #paintherapy

This PSA from the U.S. Food and Drug Administration (FDA) shows that it is important to remove unused prescription opioid medicines from your home. A woman r...

04/27/2019
Keep Your Family Safe From Unused Opioid Pain Medicines (30 Secs)

Today is National Prescription Drug Take Back Day!

Watch the PSA: https://youtu.be/4ZyP_lyXWHI

“Far too many Americans, both teens and adults, are gaining access to opioids for the first time from the medicine cabinets of their parents, relatives and friends. Millions of unused opioid pills should not be readily available and easily accessible in our homes,” said Douglas Throckmorton, MD, the deputy director of regulatory programs in the FDA’s Center for Drug Evaluation and Research. “Our ‘Remove the Risk’ campaign serves to both educate Americans on this issue and provide them with easy-to-follow steps to take so they can immediately remove prescription opioids from their homes and avoid unintentionally contributing to the risk of misuse or abuse of these drugs by a friend or loved one.”

http://bit.ly/2DxPkDm

#PainMedicineNews #painmanagement #opioids #chronicpain #Neuropathy #NervePain #Painmedicine #jointpain #pain #medicine #painspecialists #persistentpain #pharma #pharmaceutical #DigitalHealth #HealthTalk #healthcare #healthinnovations #shingles #CDC #committee #FDA #intergrativemedicine #alternativemedicine #physicaltherapy #paintreatment #paintherapy

This PSA from the U.S. Food and Drug Administration (FDA) shows why it is important to remove unused prescription opioid medicines from your home. Members of...

04/26/2019
Keep Your Family Safe From Unused Opioid Pain Medicines (60 Secs)

FDA’s ‘Remove the Risk’ Campaign Targets Female Family Members as Opioid Gatekeepers

Watch the PSA: https://youtu.be/mh6dyPHWAMA

“If every household removed prescription opioids once they’re no longer medically needed for their prescribed purpose it would have a major impact on the opioid crisis’ hold on American families and communities, ” said Amy Abernethy, MD, the principal deputy commissioner at the FDA.

http://bit.ly/2DxPkDm

This PSA from the U.S. Food and Drug Administration (FDA) shows why it is important to remove unused prescription opioid medicines from your home. Members of...

New Tool Can Identify Poor Candidates for TKAhttp://bit.ly/2W5GAM0“Total knee arthroplasty [TKA] is a very common oper...
04/26/2019
New Tool Can Identify Poor Candidates for TKA

New Tool Can Identify Poor Candidates for TKA

http://bit.ly/2W5GAM0

“Total knee arthroplasty [TKA] is a very common operation, but as many as 30% of people who have it aren’t happy with the results,” said Gary Macfarlane, MBChB, PhD, a professor of epidemiology at the University of Aberdeen, in Scotland. “They’ve still got a lot of pain afterwards, as well as poor function. So one of the things that we’ve tried to do is identify people who are likely not to benefit from the operation.”

#PainMedicineNews #painmanagement #opioids #chronicpain #Neuropathy #NervePain #Painmedicine #jointpain #pain #medicine #painspecialists #persistentpain #pharma #pharmaceutical #DigitalHealth #HealthTalk #healthcare #healthinnovations #shingles #CDC #committee #FDA #intergrativemedicine #alternativemedicine #physicaltherapy #paintreatment #paintherapy

Boston—A new clinical prediction model by a team of Scottish researchers can help identify patients at risk for poor outcomes after total knee arthroplasty and be used to aid decision making between patients and their clinicians.

Opioids Show Slight Benefit Over Placebo for Chronic Noncancer Painhttp://bit.ly/2VZl9vT“For the most part, [this stud...
04/25/2019

Opioids Show Slight Benefit Over Placebo for Chronic Noncancer Pain

http://bit.ly/2VZl9vT

“For the most part, [this study] characterized what has been fairly well known for a while now,” said Bradley C. Martin, PharmD, PhD, a professor of pharmaceutical evaluation and policy at the University of Arkansas for Medical Sciences’ College of Pharmacy in Little Rock. “Opioids do work compared to nothing. But when you stack them up against alternatives, it’s a draw in chronic painful conditions.”

#PainMedicineNews #painmanagement #opioids #chronicpain #Neuropathy #NervePain #Painmedicine #jointpain #pain #medicine #painspecialists #persistentpain #pharma #pharmaceutical #DigitalHealth #HealthTalk #healthcare #healthinnovations #shingles #CDC #committee #FDA #intergrativemedicine #alternativemedicine #physicaltherapy #paintreatment #paintherapy

New Tool for Traumatic MSK Events Shows Promise in Predicting Recovery TimelineWatch: http://bit.ly/2W3CiofThe findings ...
04/25/2019

New Tool for Traumatic MSK Events Shows Promise in Predicting Recovery Timeline

Watch: http://bit.ly/2W3Ciof

The findings showed that the Traumatic Injuries Distress Scale (TIDS), a 12-item self-report questionnaire administered in the weeks after a patient suffering from an acute MSK injury, can predict with 97% accuracy whether a patient will experience rapid or prolonged recovery from disability. To a lesser extent, the TIDS also showed potential to predict similar recovery trajectories in depression, pain and post-traumatic stress disorder (PTSD; ≥85%).

#PainMedicineNews #painmanagement #opioids #chronicpain #Neuropathy #NervePain #Painmedicine #jointpain #pain #medicine #painspecialists #persistentpain #pharma #pharmaceutical #DigitalHealth #HealthTalk #healthcare #healthinnovations #shingles #CDC #committee #FDA #intergrativemedicine #alternativemedicine #physicaltherapy #paintreatment #paintherapy

04/24/2019
FDA: First Generic Nasal Spray Part of a Larger Plan to Improve Naloxone Access

FDA: First Generic Nasal Spray Part of a Larger Plan to Improve Naloxone Access

http://bit.ly/2W2M8a6

“Moving forward we will prioritize our review of generic drug applications for naloxone,” said Douglas Throckmorton, MD, the deputy center director for regulatory programs in the FDA’s Center for Drug Evaluation and Research. “The FDA has also taken the unprecedented step of helping to assist manufacturers to pursue approval of an over-the-counter naloxone product and is exploring other ways to increase the availability of naloxone products intended for use in the community, including whether naloxone should be co-prescribed with all or some opioid prescriptions to reduce the risk of overdose death.”

#PainMedicineNews #painmanagement #opioids #chronicpain #Neuropathy #NervePain #Painmedicine #jointpain #pain #medicine #painspecialists #persistentpain #pharma #pharmaceutical #DigitalHealth #HealthTalk #healthcare #healthinnovations #shingles #CDC #committee #FDA #intergrativemedicine #alternativemedicine #physicaltherapy #paintreatment #paintherapy

The FDA’s approval of the first generic naloxone hydrochloride nasal spray marks the first time an intranasal medication that stops or reverses an opioid overdose will be available for use in a community setting by anyone without medical training.

Epidermal Growth Factor Receptor Inhibitors Show Promise for Neuropathic PainWatch: http://bit.ly/2W3Byzt“Several year...
04/23/2019

Epidermal Growth Factor Receptor Inhibitors Show Promise for Neuropathic Pain

Watch: http://bit.ly/2W3Byzt

“Several years ago, we had a patient whose cancer was growing into the peripheral nerves and came in for treatment with an EFGR inhibitor,” said Christian Kersten, MD, PhD, a senior consultant oncologist at Southern Hospital Trust’s Center for Cancer Treatment in Kristiansand, Norway. “Suddenly, he could walk for the first time after two years because the pain was gone. And he had suffered very well-established neuropathic pain, which we had treated with all different kinds of drugs, but nothing had helped.”

#PainMedicineNews #painmanagement #opioids #chronicpain #Neuropathy #NervePain #Painmedicine #jointpain #pain #medicine #painspecialists #persistentpain #pharma #pharmaceutical #DigitalHealth #HealthTalk #healthcare #healthinnovations #shingles #CDC #committee #FDA #intergrativemedicine #alternativemedicine #physicaltherapy #paintreatment #paintherapy

Long-Awaited Federal Task Force Focused on Patient-Centered Pain Managementhttp://bit.ly/2Ubd3zB“This draft report off...
03/01/2019

Long-Awaited Federal Task Force Focused on Patient-Centered Pain Management

http://bit.ly/2Ubd3zB

“This draft report offers a wide range of treatment modalities with a framework to allow for multidisciplinary, individualized patient-centered care,” said the task force’s chair, Vanila M. Singh, MD, MACM, the chief medical officer of the HHS Office of the Assistant Secretary for Health.

#PainMedicineNews #painmanagement #opioids #chronicpain #Neuropathy #NervePain #Painmedicine #jointpain #pain #medicine #painspecialists #persistentpain #pharma #pharmaceutical #DigitalHealth #HealthTalk #healthcare #healthinnovations #shingles #CDC #committee #FDA #intergrativemedicine #alternativemedicine #physicaltherapy #paintreatment #paintherapy

Novel Perioperative Pain Program Offers Multimodal Analgesia and Continuity of Carehttp://bit.ly/2UhecG1Boston—A novel...
03/01/2019

Novel Perioperative Pain Program Offers Multimodal Analgesia and Continuity of Care

http://bit.ly/2UhecG1

Boston—A novel integrated care model of perioperative pain management is tackling the opioid crisis with a multimodal approach to pain. Although patient-centered outcomes and opioid utilization have not yet been compared with current health care delivery models, results from a recent pilot study reveal the program is feasible within a quaternary academic center. According to the study authors, the program has been successfully implemented at two Johns Hopkins sites.

#PainMedicineNews #painmanagement #opioids #chronicpain #Neuropathy #NervePain #Painmedicine #jointpain #pain #medicine #painspecialists #persistentpain #pharma #pharmaceutical #DigitalHealth #HealthTalk #healthcare #healthinnovations #shingles #CDC #committee #FDA #intergrativemedicine #alternativemedicine #physicaltherapy #paintreatment #paintherapy

Schatman on Pain: ‘The Great Medical Marijuana Hoax’Watch the interview here: http://bit.ly/2Ubbt0DBoston—In this ...
02/28/2019

Schatman on Pain: ‘The Great Medical Marijuana Hoax’

Watch the interview here: http://bit.ly/2Ubbt0D

Boston—In this episode of the “On Pain” series, Michael Schatman, PhD, discusses the current clinical science around medical marijuana and the problems he sees in the public belief around the potential of it as a pain therapy.

#PainMedicineNews #painmanagement #opioids #chronicpain #Neuropathy #NervePain #Painmedicine #jointpain #pain #medicine #painspecialists #persistentpain #pharma #pharmaceutical #DigitalHealth #HealthTalk #healthcare #healthinnovations #shingles #CDC #committee #FDA #intergrativemedicine #alternativemedicine #physicaltherapy #paintreatment #paintherapy

Address

545 W 45th St
New York, NY
10036

Alerts

Be the first to know and let us send you an email when Pain Medicine News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Pain Medicine News:

Videos

Nearby media companies


Other Media/News Companies in New York

Show All